Invasive mucinous urachal adenocarcinoma: A case report of surgical management and insights from the literature

IF 0.6 Q4 SURGERY
Manar Shukri Jaber , Sondos Mojahed , Bayan Abu Rajab , Rahaf Yousef Shalodi , Khalil N.M. Abuzaina , Jamal Ata Jaber
{"title":"Invasive mucinous urachal adenocarcinoma: A case report of surgical management and insights from the literature","authors":"Manar Shukri Jaber ,&nbsp;Sondos Mojahed ,&nbsp;Bayan Abu Rajab ,&nbsp;Rahaf Yousef Shalodi ,&nbsp;Khalil N.M. Abuzaina ,&nbsp;Jamal Ata Jaber","doi":"10.1016/j.ijscr.2024.110524","DOIUrl":null,"url":null,"abstract":"<div><h3>Introduction and Importance</h3><div>Urachal carcinoma (UrC) is a rare bladder malignancy originating from the urachus. Comprising around 90 % adenocarcinomas, most cases are invasive. Urachal adenocarcinoma is less common than its non-urachal counterpart and is recognized for its aggressive nature, often diagnosed at advanced stages with a poor prognosis. Early stages typically present as asymptomatic, making timely diagnosis challenging.</div></div><div><h3>Case Presentation</h3><div>We present the case of a 58-year-old female who exhibited painless hematuria, leading to further investigation. The definitive diagnosis of invasive mucinous urachal adenocarcinoma was established through cystoscopy and transurethral resection of bladder tumor (TURBT). Surgical intervention was undertaken to manage the condition.</div></div><div><h3>Clinical Discussion</h3><div>The gold standard treatment for muscle-invasive UrC is radical cystectomy. This case underscores the importance of recognizing urinary symptoms and utilizing appropriate diagnostic procedures to identify this rare malignancy early. The surgical approach is crucial in improving patient outcomes, especially in advanced cases.</div></div><div><h3>Conclusion</h3><div>Invasive mucinous urachal adenocarcinoma is a rare but aggressive cancer that requires prompt diagnosis and intervention. Surgical management proved effective in this case, emphasizing the need for awareness and regular follow-up in patients to monitor for recurrence.</div></div>","PeriodicalId":48113,"journal":{"name":"International Journal of Surgery Case Reports","volume":null,"pages":null},"PeriodicalIF":0.6000,"publicationDate":"2024-10-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Surgery Case Reports","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2210261224013051","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"SURGERY","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction and Importance

Urachal carcinoma (UrC) is a rare bladder malignancy originating from the urachus. Comprising around 90 % adenocarcinomas, most cases are invasive. Urachal adenocarcinoma is less common than its non-urachal counterpart and is recognized for its aggressive nature, often diagnosed at advanced stages with a poor prognosis. Early stages typically present as asymptomatic, making timely diagnosis challenging.

Case Presentation

We present the case of a 58-year-old female who exhibited painless hematuria, leading to further investigation. The definitive diagnosis of invasive mucinous urachal adenocarcinoma was established through cystoscopy and transurethral resection of bladder tumor (TURBT). Surgical intervention was undertaken to manage the condition.

Clinical Discussion

The gold standard treatment for muscle-invasive UrC is radical cystectomy. This case underscores the importance of recognizing urinary symptoms and utilizing appropriate diagnostic procedures to identify this rare malignancy early. The surgical approach is crucial in improving patient outcomes, especially in advanced cases.

Conclusion

Invasive mucinous urachal adenocarcinoma is a rare but aggressive cancer that requires prompt diagnosis and intervention. Surgical management proved effective in this case, emphasizing the need for awareness and regular follow-up in patients to monitor for recurrence.
浸润性粘液性泌尿道腺癌:关于手术治疗的病例报告和文献启示。
导言和重要性:尿道癌(UrC)是一种源自尿道的罕见膀胱恶性肿瘤。腺癌约占 90%,大多数病例为浸润性。尿道腺癌的发病率低于非尿道腺癌,其侵袭性较强,通常在晚期才被确诊,预后较差。早期通常无症状,因此及时诊断具有挑战性:本病例是一名 58 岁女性的病例,患者出现无痛性血尿,因此需要进一步检查。通过膀胱镜检查和经尿道膀胱肿瘤切除术(TURBT),最终确诊为浸润性粘液性膀胱腺癌。临床讨论:临床讨论:肌肉浸润性膀胱癌的金标准治疗方法是根治性膀胱切除术。本病例强调了识别泌尿系统症状和利用适当诊断程序及早发现这种罕见恶性肿瘤的重要性。手术方法对改善患者预后至关重要,尤其是晚期病例:浸润性粘液性泌尿道腺癌是一种罕见但具有侵袭性的癌症,需要及时诊断和干预。手术治疗在本病例中证明是有效的,这强调了对患者进行宣传和定期随访以监测复发的必要性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
1.10
自引率
0.00%
发文量
1116
审稿时长
46 days
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信